Screener
Twist Bioscience Corporation TWST EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Twist Bioscience Corporation’s reported figures.
Based on trailing twelve months.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
FAQ
- What is Twist Bioscience Corporation's EBITDA margin?
- Twist Bioscience Corporation (TWST) reported EBITDA margin of -27.9% in Q1 2026.
- How has Twist Bioscience Corporation's EBITDA margin changed year-over-year?
- Twist Bioscience Corporation's EBITDA margin increased by 44.1% year-over-year, from -49.9% to -27.9%.
- What is the long-term trend for Twist Bioscience Corporation's EBITDA margin?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's EBITDA margin has grown at a -27.7% compound annual growth rate (CAGR), from -108% to -29.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Twist Bioscience Corporation's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude